Cargando…

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma

Objective: Pancreatic ductal adenocarcinoma (PDAC) is highly lethal. Although progress has been made in the treatment of PDAC, its prognosis remains unsatisfactory. This study aimed to develop novel prognostic genes related to glycolysis in PDAC and to apply these genes to new risk stratification. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Wenjing, He, Xin, Gong, Pengju, Yang, Yan, Huang, Sirui, Zeng, Yifan, Wei, Lei, Zhang, Jingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261051/ https://www.ncbi.nlm.nih.gov/pubmed/34249078 http://dx.doi.org/10.3389/fgene.2021.639246

Ejemplares similares

Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes
por: Xie, Haoran, et al.
Publicado: (2022)

Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma
por: Zhu, Zhi-gang, et al.
Publicado: (2022)

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
por: Klett, Hagen, et al.
Publicado: (2018)

Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
por: Mishra, Nitish Kumar, et al.
Publicado: (2019)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

IGFLR1 as a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates
por: Song, Wenjing, et al.
Publicado: (2020)

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
por: Pervin, Jannat, et al.
Publicado: (2023)

Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma
por: Zhang, Xiu‐Ping, et al.
Publicado: (2021)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
por: Ren, Min, et al.
Publicado: (2023)

Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
por: Penny, Hweixian Leong, et al.
Publicado: (2021)

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma
por: Barrett, Michael T, et al.
Publicado: (2017)

Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma
por: Wang, Yuxin, et al.
Publicado: (2022)

Exploring the key genetic association between chronic pancreatitis and pancreatic ductal adenocarcinoma through integrated bioinformatics
por: Guo, Kai, et al.
Publicado: (2023)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Combining Single-Cell and Transcriptomic Data Revealed the Prognostic Significance of Glycolysis in Pancreatic Cancer
por: Chen, Liang, et al.
Publicado: (2022)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

A Prognostic Survival Model of Pancreatic Adenocarcinoma Based on Metabolism-Related Gene Expression
por: Xie, Lin-ying, et al.
Publicado: (2022)

Glycolysis gene expression profilings screen for prognostic risk signature of hepatocellular carcinoma
por: Jiang, Longyang, et al.
Publicado: (2019)

The Key Genes for Perineural Invasion in Pancreatic Ductal Adenocarcinoma Identified With Monte-Carlo Feature Selection Method
por: Zhu, Jin-Hui, et al.
Publicado: (2020)

Diagnostic rate of germline pathogenic variants in pancreatic ductal adenocarcinoma patients using whole genome sequencing
por: Chung, An-Ko, et al.
Publicado: (2023)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal Adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2021)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
por: Vezakis, Ioannis, et al.
Publicado: (2023)

Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma
por: Adwan, H, et al.
Publicado: (2011)

One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma
por: Li, Lei, et al.
Publicado: (2022)

Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates
por: Wei, Qin, et al.
Publicado: (2022)

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma
por: Shi, Guodong, et al.
Publicado: (2017)

Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
por: Fang, Lishan, et al.
Publicado: (2023)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

A Distinct Glucose Metabolism Signature of Lung Adenocarcinoma With Prognostic Value
por: Li, Ding, et al.
Publicado: (2022)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
por: Zhou, Kangjie, et al.
Publicado: (2022)

Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma
por: Song, Yuqi, et al.
Publicado: (2022)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3dujpq56g4kb58o2j917jn6bca